Ghrelin vs Sermorelin
A neutral, side-by-side comparison of two performance & growth hormone peptides — their mechanisms, dosing ranges, administration routes, side effects, and research evidence. For research and educational purposes only.
Ghrelin
Endogenous 28-amino acid peptide secreted primarily by the stomach that functions as both the primary hunger signal and a potent growth hormone secretagogue. The n-octanoyl modification at Ser-3 (acylated form) is required for GHS-R1a receptor binding and GH-stimulating activity. Understanding ghrelin explains the mechanism behind the entire GHRP class of research peptides.
Full profileSermorelin
Sermorelin is a synthetic analog of the first 29 amino acids of GHRH (Growth Hormone-Releasing Hormone). It was FDA-approved for pediatric GH deficiency diagnosis and is widely used off-label in anti-aging and performance medicine. It stimulates pulsatile GH release more physiologically than exogenous GH.
Full profile| Ghrelin | Sermorelin | |
|---|---|---|
| Category | Performance & Growth Hormone | Performance & Growth Hormone |
| Also known as | GHRL, growth hormone-releasing peptide endogenous, ghrelinergic peptide, acyl ghrelin | GHRH 1-29, GRF 1-29 NH2, Geref |
| Evidence | Investigational (in trials) | FDA-approved |
| Dosing range | 0.5mcg/kg–2mcg/kg mcg/kg, IV or SC bolus; endogenous levels peak pre-meal | 100mcg–500mcg mcg, once daily (before sleep) |
| Administration | Intravenous (research), Subcutaneous injection | Subcutaneous injection |
| Key side effects | Appetite stimulation, Transient hyperglycemia, Water retention, GH pulse stimulation | Injection site redness, Headache, Flushing, Dizziness |
| Cited sources | 2 references | 1 reference |
Key differences
- Evidence level differs: Ghrelin is investigational (in trials), while Sermorelin is fda-approved.
- Administration: Ghrelin — Intravenous (research), Subcutaneous injection; Sermorelin — Subcutaneous injection.
- Dosing units differ: Ghrelin is dosed in mcg/kg, Sermorelin in mcg — they operate at different scales.
- Frequency: Ghrelin is typically IV or SC bolus; endogenous levels peak pre-meal; Sermorelin is once daily (before sleep).
- Research depth: this profile cites 2 sources for Ghrelin vs 1 for Sermorelin.
How each works
Ghrelin
Ghrelin was discovered in 1999 as the endogenous ligand for the GHS-R1a receptor. Its acylated form activates GH release from the pituitary, stimulates appetite via NPY/AgRP hypothalamic neurons, and modulates energy homeostasis and fat storage. The des-acyl form (majority of circulating ghrelin) lacks GHS-R1a activity but has independent cardiovascular and cellular effects.
Sermorelin
Sermorelin works by binding pituitary GHRH receptors to stimulate GH secretion within the body's natural feedback loop. Unlike synthetic GH, it does not suppress endogenous production. Clinical studies show improved body composition, sleep quality, and IGF-1 levels in GH-deficient adults. Its short half-life (~10 min) means it requires daily dosing.
This comparison aggregates public research and structured profile data for informational purposes only. It is not medical advice and does not recommend either compound for human use. Consult a qualified healthcare provider before considering any peptide.